10.37
1.28%
+0.13
Iovance Biotherapeutics Inc (IOVA) 最新ニュース
Panagora Asset Management Inc. Has $2.82 Million Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World
Defense World
Reviewing Iovance Biotherapeutics (NASDAQ:IOVA) & Vaxart (NASDAQ:VXRT) - Defense World
Defense World
Why Iovance Biotherapeutics (IOVA) Shares Are Exploding Higher - MSN
MSN
Amgen’s Imdelltra Becomes First Bi-specific T-cell engager for Advanced SCLC - BioSpace
BioSpace
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Amgen’s Imdelltra Becomes First Bi-specific T-cell engager for Advanced SCLC - BioSpace
BioSpace
BMS’s Breyanzi Secures Fourth FDA Approval, for Follicular Lymphoma - BioSpace
BioSpace
BMS’s Breyanzi Secures Fourth FDA Approval, for Follicular Lymphoma - BioSpace
BioSpace
4 Small-Cap Value Stocks That Could Go Parabolic
The Motley Fool
How To Trade (IOVA) - Stock Traders Daily
Stock Traders Daily
Iovance (IOVA) Q1 Loss Wider Than Expected, Revenues Nil - Yahoo News UK
Yahoo News UK
BMS’s Breyanzi Secures Fourth FDA Approval, for Follicular Lymphoma - BioSpace
BioSpace
Looking At Iovance Biotherapeutics's Recent Unusual Options Activity - Iovance Biotherapeutics (NASDAQ:IO - Benzinga
Benzinga
Iovance Biotherapeutics' Amtagvi: Innovative Therapy, Financial Strain (Downgrade) (IOVA) - Seeking Alpha
Seeking Alpha
HC Wainwright Reiterates “Buy” Rating for Iovance Biotherapeutics (NASDAQ:IOVA) - Defense World
Defense World
Iovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Down to $13.45 - Defense World
Defense World
IOVA (Iovance Biotherapeutics) Net Issuance of Preferred St - GuruFocus.com
GuruFocus.com
Iovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Down to $13.45 - MarketBeat
MarketBeat
Iovance Biotherapeutics (NASDAQ:IOVA) Earns "Buy" Rating from HC Wainwright - MarketBeat
MarketBeat
Earnings call: Iovance Biotherapeutics posts Q1 2024 results By Investing.com - Investing.com
Investing.com
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Iovance Q1 Earnings Review: Not Enough Data To Draw Conclusions On Amtagvi (NASDAQ:IOVA) - Seeking Alpha
Seeking Alpha
Why Iovance Stock Is Down 18% Today - Yahoo Finance
Yahoo Finance
Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ... - Yahoo Finance
Yahoo Finance
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Iovance Biotherapeutics's Options: A Look at What the Big Money is Thinking - Iovance Biotherapeutics (NA - Benzinga
Benzinga
Iovance Biotherapeutics Reports a Q1 Revenue Miss
The Motley Fool
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates - Yahoo Finance
Yahoo Finance
Iovance Biotherapeutics: Q1 Earnings Snapshot - Darien Times
Darien Times
Iovance Q1 Earnings Review: Not Enough Data To Draw Conclusions On Amtagvi (NASDAQ:IOVA) - Seeking Alpha
Seeking Alpha
Iovance Biotherapeutics: Q1 Earnings Snapshot | News | bakersfield.com - The Bakersfield Californian
The Bakersfield Californian
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates - GlobeNewswire
GlobeNewswire
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates - Yahoo Finance
Yahoo Finance
Iovance Biotherapeutics: Q1 Earnings Snapshot - Darien Times
Darien Times
Iovance Biotherapeutics (IOVA) to Release Earnings on Thursday - Defense World
Defense World
Investors Purchase Large Volume of Call Options on Iovance Biotherapeutics (NASDAQ:IOVA) - Defense World
Defense World
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks Investment Research
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect - Yahoo Finance
Yahoo Finance
Iovance (IOVA) Q1 Loss Wider Than Expected, Revenues Nil - Yahoo Singapore News
Yahoo Singapore News
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect - Yahoo Finance
Yahoo Finance
Got $500? These Hot Growth Stocks Are Screaming Buys Right Now
The Motley Fool
June 14th Options Now Available For Iovance Biotherapeutics (IOVA) - Nasdaq
Nasdaq
Great week for Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) institutional investors after losing 43% over the previous ... - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Sees Significant Increase in Short Interest - Defense World
Defense World
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Purchased by Handelsbanken Fonder AB - Defense World
Defense World
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May ... - GlobeNewswire
GlobeNewswire
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
GlobeNewswire Inc.
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May ... - GlobeNewswire
GlobeNewswire
大文字化:
|
ボリューム (24 時間):